ID   1433B_BOVIN             Reviewed;         246 AA.
AC   P68250; P29358; Q0VCL1;
DT   25-OCT-2004, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 2.
DT   23-FEB-2022, entry version 120.
DE   RecName: Full=14-3-3 protein beta/alpha;
DE   AltName: Full=Protein kinase C inhibitor protein 1;
DE            Short=KCIP-1;
DE   Contains:
DE     RecName: Full=14-3-3 protein beta/alpha, N-terminally processed;
GN   Name=YWHAB;
OS   Bos taurus (Bovine).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Laurasiatheria; Artiodactyla; Ruminantia; Pecora; Bovidae;
OC   Bovinae; Bos.
OX   NCBI_TaxID=9913;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM LONG).
RC   STRAIN=Hereford; TISSUE=Fetal pons;
RG   NIH - Mammalian Gene Collection (MGC) project;
RL   Submitted (AUG-2006) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   PROTEIN SEQUENCE OF 2-246.
RX   PubMed=1671102; DOI=10.1016/0022-2836(91)90616-e;
RA   Isobe T., Ichimura T., Sunaya T., Okuyama T., Takahashi N., Kuwano R.,
RA   Takahashi Y.;
RT   "Distinct forms of the protein kinase-dependent activator of tyrosine and
RT   tryptophan hydroxylases.";
RL   J. Mol. Biol. 217:125-132(1991).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM SHORT).
RA   Jones J.M., Niikura T., Pinke R.M., Guo W., Molday L., Leykam J.,
RA   McConnell D.G.;
RT   "Expression of 14-3-3 proteins in bovine retinal photoreceptors.";
RL   Submitted (JAN-1998) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   FUNCTION.
RX   PubMed=7931346; DOI=10.1046/j.1471-4159.1994.63051908.x;
RA   Tanji M., Horwitz R., Rosenfeld G., Waymire J.C.;
RT   "Activation of protein kinase C by purified bovine brain 14-3-3: comparison
RT   with tyrosine hydroxylase activation.";
RL   J. Neurochem. 63:1908-1916(1994).
CC   -!- FUNCTION: Adapter protein implicated in the regulation of a large
CC       spectrum of both general and specialized signaling pathways. Binds to a
CC       large number of partners, usually by recognition of a phosphoserine or
CC       phosphothreonine motif. Binding generally results in the modulation of
CC       the activity of the binding partner. Negative regulator of
CC       osteogenesis. Blocks the nuclear translocation of the phosphorylated
CC       form (by AKT1) of SRPK2 and antagonizes its stimulatory effect on
CC       cyclin D1 expression resulting in blockage of neuronal apoptosis
CC       elicited by SRPK2. Negative regulator of signaling cascades that
CC       mediate activation of MAP kinases via AKAP13.
CC       {ECO:0000250|UniProtKB:P31946, ECO:0000269|PubMed:7931346}.
CC   -!- SUBUNIT: Homodimer (By similarity). Interacts with SAMSN1 and PRKCE (By
CC       similarity). Interacts with AKAP13. Interacts with SSH1 and
CC       TORC2/CRTC2. Interacts with ABL1; the interaction results in
CC       cytoplasmic location of ABL1 and inhibition of cABL-mediated apoptosis.
CC       Interacts with ROR2 (dimer); the interaction results in phosphorylation
CC       of YWHAB on tyrosine residues. Interacts with GAB2. Interacts with YAP1
CC       (phosphorylated form). Interacts with the phosphorylated (by AKT1) form
CC       of SRPK2. Interacts with PKA-phosphorylated AANAT. Interacts with
CC       MYO1C. Interacts with SIRT2 (By similarity). Interacts with the 'Thr-
CC       369' phosphorylated form of DAPK2 (By similarity). Interacts with
CC       PI4KB, TBC1D22A and TBC1D22B. Interacts with the 'Ser-1134' and 'Ser-
CC       1161' phosphorylated form of SOS1 (By similarity). Interacts (via
CC       phosphorylated form) with YWHAB; this interaction occurs in a protein
CC       kinase AKT1-dependent manner (By similarity). Interacts with SLITRK1.
CC       Interacts with SYNPO2 (phosphorylated form); YWHAB competes with ACTN2
CC       for interaction with SYNPO2 (By similarity). Interacts with RIPOR2 (via
CC       phosphorylated form); this interaction occurs in a chemokine-dependent
CC       manner and does not compete for binding of RIPOR2 with RHOA nor blocks
CC       inhibition of RIPOR2-mediated RHOA activity (By similarity). Interacts
CC       with MARK2 and MARK3 (By similarity). Interacts with TESK1; the
CC       interaction is dependent on the phosphorylation of TESK1 'Ser-439' and
CC       inhibits TESK1 kinase activity (By similarity). Interacts with MEFV (By
CC       similarity). {ECO:0000250|UniProtKB:P31946,
CC       ECO:0000250|UniProtKB:Q9CQV8}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:P31946}.
CC       Melanosome {ECO:0000250|UniProtKB:P31946}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative initiation; Named isoforms=2;
CC         Comment=It is uncertain whether isoform Short is produced by
CC         alternative initiation or another biological event.;
CC       Name=Long;
CC         IsoId=P68250-1; Sequence=Displayed;
CC       Name=Short;
CC         IsoId=P68250-2; Sequence=VSP_018631;
CC   -!- PTM: The alpha, brain-specific form differs from the beta form in being
CC       phosphorylated. Phosphorylated on Ser-60 by protein kinase C delta type
CC       catalytic subunit in a sphingosine-dependent fashion. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the 14-3-3 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BC120112; AAI20113.1; -; mRNA.
DR   EMBL; AF043736; AAC02090.1; -; mRNA.
DR   PIR; S13467; S13467.
DR   RefSeq; NP_777219.2; NM_174794.2.
DR   SMR; P68250; -.
DR   STRING; 9913.ENSBTAP00000022411; -.
DR   iPTMnet; P68250; -.
DR   PaxDb; P68250; -.
DR   PeptideAtlas; P68250; -.
DR   PRIDE; P68250; -.
DR   GeneID; 286863; -.
DR   KEGG; bta:286863; -.
DR   CTD; 7529; -.
DR   eggNOG; KOG0841; Eukaryota.
DR   HOGENOM; CLU_058290_1_0_1; -.
DR   InParanoid; P68250; -.
DR   OrthoDB; 1176818at2759; -.
DR   TreeFam; TF102003; -.
DR   Proteomes; UP000009136; Unplaced.
DR   GO; GO:0005737; C:cytoplasm; ISS:AgBase.
DR   GO; GO:0042470; C:melanosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; ISS:AgBase.
DR   GO; GO:0019904; F:protein domain specific binding; ISS:AgBase.
DR   GO; GO:0004860; F:protein kinase inhibitor activity; ISS:UniProtKB.
DR   GO; GO:0034613; P:cellular protein localization; IBA:GO_Central.
DR   GO; GO:0045744; P:negative regulation of G protein-coupled receptor signaling pathway; ISS:UniProtKB.
DR   GO; GO:0006605; P:protein targeting; ISS:AgBase.
DR   GO; GO:0007165; P:signal transduction; IBA:GO_Central.
DR   Gene3D; 1.20.190.20; -; 1.
DR   InterPro; IPR000308; 14-3-3.
DR   InterPro; IPR023409; 14-3-3_CS.
DR   InterPro; IPR036815; 14-3-3_dom_sf.
DR   InterPro; IPR023410; 14-3-3_domain.
DR   PANTHER; PTHR18860; PTHR18860; 1.
DR   Pfam; PF00244; 14-3-3; 1.
DR   PIRSF; PIRSF000868; 14-3-3; 1.
DR   PRINTS; PR00305; 1433ZETA.
DR   SMART; SM00101; 14_3_3; 1.
DR   SUPFAM; SSF48445; SSF48445; 1.
DR   PROSITE; PS00796; 1433_1; 1.
DR   PROSITE; PS00797; 1433_2; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative initiation; Cytoplasm; Direct protein sequencing;
KW   Isopeptide bond; Nitration; Phosphoprotein; Reference proteome;
KW   Ubl conjugation.
FT   MOD_RES         P68250-2:1
FT                   /note="toto"
FT                   /evidence="titi"
FT   TRANSIT         1..?
FT                   /note="toto"
FT                   /evidence="titi"
FT   CHAIN           ?..245
FT                   /note="toto"
FT                   /evidence="titi"
FT   SIGNAL          <1..?
FT                   /note="toto"
FT                   /evidence="titi"
FT   CHAIN           31..?137
FT                   /note="toto"
FT                   /evidence="titi"
FT   CHAIN           ?69..255
FT                   /note="toto"
FT                   /evidence="titi"
FT   CHAIN           1..>24
FT                   /note="toto"
FT                   /evidence="titi"
FT   CHAIN           <1..>129
FT                   /note="toto"
FT                   /evidence="titi"
FT   CHAIN           <1..55
FT                   /note="toto"
FT                   /evidence="titi"
SQ   SEQUENCE   246 AA;  28081 MW;  CABA32314D86800D CRC64;
     MTMDKSELVQ KAKLAEQAER YDDMAAAMKA VTEQGHELSN EERNLLSVAY KNVVGARRSS
     WRVISSIEQK TERNEKKQQM GKEYREKIEA ELQDICNDVL QLLDKYLIPN ATQPESKVFY
     LKMKGDYFRY LSEVASGDNK QTTVSNSQQA YQEAFEISKK EMQPTHPIRL GLALNFSVFY
     YEILNSPEKA CSLAKTAFDE AIAELDTLNE ESYKDSTLIM QLLRDNLTLW TSENQGDEGD
     AGEGEN
//
